Care for people with rare and less common cancers ‘delayed and fragmented’, new report reveals

1 September 2025 - A national survey of nearly 2,500 people affected by cancer has found those with a rare ...

Read more →

Bewildering PBAC decision a missed opportunity to ensure Australian cancer patients not left behind

23 August 2025 - MSD Australia & New Zealand is astonished that after eight years of dialogue and consideration, the ...

Read more →

Committee rejects application for medication Keytruda to be subsidised for Aussies with cancer

23 August 2025 - Australians with rare cancers like Natalie Willacy have just been handed a devastating hit, which could leave ...

Read more →

Norgine welcomes PBS listing in Australia of Ifinwil (eflornithine) for patients with high-risk neuroblastoma

1 August 2025 - Approximately 50 children in Australia are diagnosed with neuroblastoma each year, with nearly half classified as having ...

Read more →

Life-saving breast cancer drug now cheaper thanks to expansion of the PBS

1 July 2025 - A potentially life-saving treatment for early-stage breast cancer will become much more affordable for hundreds of ...

Read more →

‘The sky’s the limit’: how Australian scientists rewrote the cancer script

20 June 2025 - A major shift in cancer treatment will be publicly funded and is set to dramatically increase the ...

Read more →

Come to grips’: fighting lymphoma from home

28 April 2025 - Australian patients with the most common form of lymphoma will for the first time have access ...

Read more →

Multiple myeloma drug subsidised after treatment costs ballooned

24 April 2025 - It’s one of the few cancers still considered incurable, and those diagnosed with multiple myeloma will likely ...

Read more →

This immunotherapy drug helped me beat cancer - instead of $229k it now costs $31

8 March 2025 - When she was just 26-years-old, Bianca Tesoriero’s life changed in an instant, following a visit to her ...

Read more →

Life-saving lung cancer drug added to PBS, slashing price from $10,000 a month to $30 per script

1 February 2025 - Australians diagnosed with a rare form of lung cancer will now have access to a life-saving ...

Read more →

Cheaper medicine for lung cancer patients

2 February 2025 - The Australian Government is listing Retevmo (selpercatinib) on the PBS for the first time to treat advanced ...

Read more →

Changes to the PBS listings for Opdualag and Vyxeos

1 December 2024 - As of 1 December 2024, combination chemotherapy medicines, Opdualag and Vyxeos, will be transitioned from the Highly ...

Read more →

Evidence of clinical benefit of cancer medicines considered for funding in Australia

14 November 2024 - The objective was to describe the type of evidence and the clinical benefit of cancer medicines ...

Read more →

Last hope: why it’s costing me $20,000 a month to stay alive

4 November 2024 - It’s Jemma Juckes’ last throw of the dice as she awaits a decision on whether a new ...

Read more →

‘Brighter future’ for blood cancer patients battling rare condition

4 November 2024 - Mycosis fungoides affects three in every million Australians; for those few sufferers it is a near-constant agony ...

Read more →